Arrivent BioPharma, Inc. (AVBP)
26.73
-0.27
(-1.00%)
USD |
NASDAQ |
May 22, 16:00
26.74
+0.01
(+0.04%)
After-Hours: 20:00
Arrivent BioPharma Total Liabilities (Quarterly) : 25.32M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ocugen, Inc. | 51.10M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Agenus, Inc. | 414.44M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 349.30M |
| Shareholders Equity (Quarterly) | 323.98M |
| Debt to Equity Ratio | 0.0013 |
| Current Ratio | 13.95 |
| Net Debt Paydown Yield | -0.01% |